Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression in elderly patients: a subgroup analysis of HOT/NJLCG2001.

Autor: Tateishi K; First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan., Mizugaki H; Department of Respiratory Medicine, NHO Hokkaido Cancer Center, Sapporo, Japan.; Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Ikezawa Y; Department of Respiratory Medicine, Oji General Hospital, Tomakomai, Japan.; Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo, Japan., Morita R; Department of Respiratory Medicine, Akita Kousei Medical Center, Akita, Japan., Yokoo K; Department of Respiratory Medicine, Teine Keijinkai Hospital, Sapporo, Japan., Sumi T; Department of Respiratory Medicine, Hakodate Goryoukaku Hospital, Hakodate, Japan., Aso M; Department of Respiratory Medicine, Yamagata Prefectural Central Hospital, Yamagata, Japan., Kikuchi H; Department of Respiratory Medicine, Obihiro-Kousei General Hospital, Obihiro, Japan., Nakamura A; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan., Sekikawa M; Department of Respiratory Medicine, Steel Memorial Muroran Hospital, Muroran, Japan., Yoshiike F; Department of Respiratory Medicine, Nagano Municipal Hospital, Nagano, Japan., Kitamura Y; Department of Respiratory Medicine, Kushiro City General Hospital, Kushiro, Japan., Kimura N; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan., Hachiya T; Department of Respiratory Medicine, Japanese Red Cross Suwa Hospital, Suwa, Japan., Tsurumi K; Department of Respiratory Medicine, Miyagi Cancer Center, Natori, Japan., Agatsuma T; Department of Respiratory Medicine, Shinshu Ueda Medical Center, Ueda, Japan., Megumi F; Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo, Japan., Nakamura K; Department of Respiratory Medicine, National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan., Jingu D; Department of Respiratory Medicine, Saka General Hospital, Shiogama, Japan., Yamamoto H; Department of Respiratory Medicine, Iida Municipal Hospital, Iida, Japan., Kosaka M; Center of Infectious Diseases, Nagano Prefectural Shinshu Medical Center, Suzaka, Japan., Yokouchi H; Department of Respiratory Medicine, NHO Hokkaido Cancer Center, Sapporo, Japan.

Publikováno v: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 Dec 04. Date of Electronic Publication: 2024 Dec 04.

Non-small cell lung cancer with synchronous brain metastases: Identification of prognostic factors in a retrospective multicenter study (HOT 1701).

Autor: Ohhara Y; Department of Medical Oncology, Hokkaido University Hospital, Kita-ku, Japan., Kojima T; Department of Respiratory Medicine, KKR Sapporo Medical Center, Toyohira-ku, Japan., Honjo O; Department of Respiratory Medicine, Sapporo Minamisanjo Hospital, Chuo-ku, Japan., Yamada N; Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, Kikusui, Japan., Sato T; Department of Respiratory Medicine, KKR Sapporo Medical Center, Toyohira-ku, Japan., Takahashi H; Department of Respiratory Medicine, Hokkaido University Hospital, Kita-ku, Japan., Takamura K; Department of Respiratory Medicine, Obihiro Kosei Hospital, Obihiro, Japan., Takashina T; Department of Respiratory Medicine, Iwamizawa Municipal General Hospital, Iwamizawa, Japan., Sukoh N; Department of Respiratory Medicine, National Hospital Organization Hokkaido Medical Center, Nishi-ku, Japan., Tanaka H; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki city, Japan., Kawai Y; Department of Respiratory Medicine, Oji General Hospital, Tomakomai, Japan., Fujita Y; Department of Respiratory Medicine, National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan., Yokoo K; Department of Respiratory Medicine, Teine Keijinkai Hospital, Teine-ku, Japan., Hommura F; Department of Respiratory Medicine, Sapporo City General Hospital Chuo-ku, Japan., Harada T; Center for Respiratory Diseases, Japan Community Healthcare Organization Hokkaido Hospital, Toyohira-ku, Japan., Honda R; Department of Respiratory Medicine, Asahi General Hospital, Chiba Prefecture, Japan., Amano T; Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Kita-ku, Japan., Dosaka-Akita H; Department of Medical Oncology, Hokkaido University Hospital, Kita-ku, Japan., Oizumi S; Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, Kikusui, Japan., Kinoshita I; Department of Medical Oncology, Hokkaido University Hospital, Kita-ku, Japan.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2024 Oct 05; Vol. 6 (1), pp. vdae168. Date of Electronic Publication: 2024 Oct 05 (Print Publication: 2024).

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).

Autor: Nishioka N; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Respiratory Medicine, Fukuchiyama City Hospital, Kyoto, Japan., Imai H; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Yamane 1397-1, Hidaka City, Saitama, Japan. m06701014@gunma-u.ac.jp., Endo M; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.; Division of Diagnostic Radiology, Shizuoka Cancer Center, Shizuoka, Japan., Notsu A; Division of Clinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan., Doshita K; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Igawa S; Department of Respiratory Medicine, Kitasato University School of Medicine, Kanagawa, Japan., Yokouchi H; Department of Respiratory Medicine, NHO Hokkaido Cancer Center, Hokkaido, Japan., Ninomiya T; Department of Thoracic Oncology and Medicine, NHO Shikoku Cancer Center, Matsuyama, Ehime, Japan., Tokito T; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan., Soda S; Department of Pulmonary and Clinical Immunology, Dokkyo Medical University School of Medicine, Tohigi, Japan., Fujiwara T; Department of Respiratory Internal Medicine, Yokosuka Kyosai Hospital, Kanagawa, Japan., Asao T; Department of Respiratory Medicine, Graduate School of Medicine, Juntendo University, Tokyo, Japan., Nakamichi S; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan., Kawamura T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Inomata M; 1st Department of Internal Medicine, Toyama University Hospital, Toyama, Japan., Nakashima K; Division of Medical Oncology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Shimane University, Shimane, Japan., Ito K; Respiratory Center, Matsusaka Municipal Hospital, Mie, Japan., Goto Y; Department of Respiratory Medicine, Fujita Health University School of Medicine, Aichi, Japan., Umeda Y; Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan., Hirai S; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Ushio R; Department of Thoracic Oncology, Kanagawa Cancer Center, Kanagawa, Japan., Yokoo K; Department of Respiratory Medicine, Teine Keijinkai Hospital, Hokkaido, Japan., Takeda T; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Fukui T; Department of Respiratory Medicine, Shonan Kamakura General Hospital, Kanagawa, Japan., Ishihara M; Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan., Osaki T; Department of Respiratory Medicine, Shibukawa Medical Center, Gunma, Japan., Kubo S; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan., Fujiwara T; Department of Genomic Medicine, Mie University Hospital, Mie, Japan., Yamamoto C; Department of Respiratory Medicine, Fukuchiyama City Hospital, Kyoto, Japan., Tsuda T; Division of Respiratory Medicine, Toyama Prefectural Central Hospital, Toyama, Japan., Tamura N; Division of Respiratory Diseases, Department of Internal Medicine, Atsugi City Hospital, Kanagawa, Japan., Hosokawa S; Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan., Chihara Y; Department of Respiratory Medicine, Uji-Tokushukai Medical Center, Kyoto, Japan., Ikeda S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan., Furuya N; Division of Respiratory Medicine, Department of Internal Medicine, St Marianna University School of Medicine, Kanagawa, Japan., Nakahara Y; Department of Respiratory Medicine, Kitasato University School of Medicine, Kanagawa, Japan., Miura S; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan., Okamoto H; Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.

Publikováno v: Targeted oncology [Target Oncol] 2024 May; Vol. 19 (3), pp. 423-433. Date of Electronic Publication: 2024 Apr 13.

Extensive-Disease Small-Cell Lung Cancer With Severe Immune-Related Adverse Events Due to Atezolizumab Maintaining a Complete Response for Two Years: A Case Report.

Autor: Kudo S; Department of Respiratory Medicine, Kushiro City General Hospital, Kushiro, JPN., Yokoo K; Department of Respiratory Medicine, Teine Keijinkai Hospital, Sapporo, JPN., Tanaka N; Department of Respiratory Medicine, Kushiro City General Hospital, Kushiro, JPN., Yamada G; Department of Respiratory Medicine, Teine Keijinkai Hospital, Sapporo, JPN., Kitamura Y; Department of Respiratory Medicine, Kushiro City General Hospital, Kushiro, JPN.

Publikováno v: Cureus [Cureus] 2024 Mar 16; Vol. 16 (3), pp. e56302. Date of Electronic Publication: 2024 Mar 16 (Print Publication: 2024).

P1.08D.01 The Efficacy of Durvalumab after Concurrent Chemoradiotherapy for EGFR-Mutated Stage III Non-Small Cell Lung Cancer (NEJ063).

Autor: Kida, G., Fujisaki, T., Miyauchi, E., Kikuchi, H., Hommura, F., Yokoo, K., Tanaka, H., Kikuchi, T., Jingu, D., Sugisaka, J., Watanabe, K., Yoshimura, N., Nakagawa, T., Nogawa, H., Sato, M., Nakazawa, K., Soda, S., Takigami, A., Arai, D., Masubuchi, K.

Publikováno v: Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS182-S183, 2p